Cargando…

A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity

We previously reported that 7-hydroxy-5, 4’-dimethoxy-2-arylbenzofuran (HDAB) purified from Livistona chinensis is a key active agent. The present study investigated the function and molecular mechanism of HDAB. HDAB treatment of cervical cancer cells resulted in S phase arrest and apoptosis, togeth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hongbo, Zeng, Xiaobin, Gao, Chunmei, Ming, Pinghong, Zhang, Jianping, Guo, Caiping, Zhou, Lanzhen, Lu, Yin, Wang, Lijun, Huang, Laiqiang, He, Xiangjiu, Mei, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455115/ https://www.ncbi.nlm.nih.gov/pubmed/26041102 http://dx.doi.org/10.1038/srep10893

Ejemplares similares

Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents
por: Yun, Yinling, et al.
Publicado: (2021)

A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway
por: Ming, Pinghong, et al.
Publicado: (2016)

New 2-Arylbenzofurans from the Root Bark of Artocarpus lakoocha
por: Sritularak, Boonchoo, et al.
Publicado: (2010)

Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
por: Vesely, Ondrej, et al.
Publicado: (2021)

Semi-synthesis, structural modification and biological evaluation of 5-arylbenzofuran neolignans
por: Lin, Ding, et al.
Publicado: (2018)

Insight into the PTP1B Inhibitory Activity of Arylbenzofurans: An In Vitro and In Silico Study
por: Shrestha, Srijan, et al.
Publicado: (2019)

Palladium-Catalyzed C–H Arylation of Benzofurans with Triarylantimony Difluorides for the Synthesis of 2-Arylbenzofurans
por: Kitamura, Yuki, et al.
Publicado: (2020)

PICT-1 triggers a pro-death autophagy through inhibiting rRNA transcription and AKT/mTOR/p70S6K signaling pathway
por: Chen, Hongbo, et al.
Publicado: (2016)

Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity
por: Coy-Barrera, Ericsson
Publicado: (2020)

An Arylbenzofuran, Stilbene Dimers, and Prenylated Diels–Alder Adducts as Potent Diabetic Inhibitors from Morus bombycis Leaves
por: Ju, Seon Min, et al.
Publicado: (2023)

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013)

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells
por: Cao, Wei, et al.
Publicado: (2015)

Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro
por: Li, Shuyi, et al.
Publicado: (2021)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

Synthesis of Moracin C and Its Derivatives with a 2-arylbenzofuran Motif and Evaluation of Their PCSK9 Inhibitory Effects in HepG2 Cells
por: Masagalli, Jagadeesh Nagarajappa, et al.
Publicado: (2021)

Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.
por: Iwadate, Y., et al.
Publicado: (1998)

Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
por: Shao, Zhengping, et al.
Publicado: (2020)

Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies
por: Ha, Manh Tuan, et al.
Publicado: (2020)

Potential Anti-Coronavirus Agents and the Pharmacologic Mechanisms
por: Yang, Yang, et al.
Publicado: (2021)

NADP(+) is an endogenous PARP inhibitor in DNA damage response and tumor suppression
por: Bian, Chunjing, et al.
Publicado: (2019)

Enhancing the anti-tumour activity of (177)Lu-DOTA-octreotate radionuclide therapy in somatostatin receptor-2 expressing tumour models by targeting PARP
por: Cullinane, Carleen, et al.
Publicado: (2020)

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?
por: Furuse, Junji
Publicado: (2019)

Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
por: Du, Yi, et al.
Publicado: (2016)

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
por: Kim, Chiho, et al.
Publicado: (2020)

PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
por: Swindall, Amanda F., et al.
Publicado: (2013)

Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition
por: Aguilar-Quesada, Rocío, et al.
Publicado: (2007)

Dynamics of endogenous PARP1 and PARP2 during DNA damage revealed by live-cell single-molecule imaging
por: Mahadevan, Jyothi, et al.
Publicado: (2022)

The Phenolics from the Roots of Livistona chinensis Show Antioxidative and Obsteoblast Differentiation Promoting Activity
por: Zeng, Xiaobin, et al.
Publicado: (2013)

New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage
por: Gu, Zongying, et al.
Publicado: (2019)

Acridine as an Anti-Tumour Agent: A Critical Review
por: Varakumar, Potlapati, et al.
Publicado: (2022)

DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition
por: Viera, Talysa, et al.
Publicado: (2020)

PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage
por: Riccio, Amanda A., et al.
Publicado: (2016)

Inhibition of DNA damage repair by artificial activation of PARP with siDNA
por: Croset, Amelie, et al.
Publicado: (2013)

PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage
por: Martire, Sara, et al.
Publicado: (2013)

SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism
por: Luna, Augustin, et al.
Publicado: (2013)

Characterization of the interactions of PARP-1 with UV-damaged DNA in vivo and in vitro
por: Purohit, Nupur K., et al.
Publicado: (2016)

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
por: Francica, Paola, et al.
Publicado: (2018)

Increased PARP Activity and DNA Damage in NSCLC Patients: The Influence of COPD
por: Tang, Jun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hm6j7fqe2g86bogv0bb9qo2flk